Thus, we propose that due to the broad expression of NNMT in primary ccRCC tumours and metastases, its association with patient survival, and its molecular functions, NNMT is a promising drug target in ccRCC. The gene discussed is NNMT; the disease is nonpapillary renal cell carcinoma.